JPMorgan Chase & Co. Boosts Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

JPMorgan Chase & Co. raised its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 10.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 183,198 shares of the company's stock after acquiring an additional 16,997 shares during the quarter. JPMorgan Chase & Co. owned approximately 1.01% of Addus HomeCare worth $24,371,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Addus HomeCare during the third quarter valued at approximately $1,622,000. Dimensional Fund Advisors LP lifted its holdings in shares of Addus HomeCare by 0.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock valued at $82,930,000 after purchasing an additional 5,421 shares during the last quarter. Point72 Asset Management L.P. boosted its position in shares of Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock worth $86,598,000 after purchasing an additional 315,602 shares in the last quarter. Victory Capital Management Inc. grew its stake in Addus HomeCare by 136.5% during the 2nd quarter. Victory Capital Management Inc. now owns 80,047 shares of the company's stock worth $9,294,000 after buying an additional 46,199 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in Addus HomeCare by 90.6% during the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company's stock worth $2,136,000 after buying an additional 8,743 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Stock Up 0.6 %

Shares of ADUS stock traded up $0.72 on Thursday, hitting $126.42. The company had a trading volume of 109,891 shares, compared to its average volume of 138,318. Addus HomeCare Co. has a twelve month low of $85.94 and a twelve month high of $136.12. The firm has a market cap of $2.29 billion, a P/E ratio of 28.93, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00. The company has a 50-day moving average price of $125.04 and a 200-day moving average price of $125.95.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare's revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.03 earnings per share. Equities research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on ADUS. Macquarie reissued an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research note on Monday, September 23rd. Citizens Jmp raised shares of Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. StockNews.com raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Wednesday, December 11th. Finally, Stephens boosted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Addus HomeCare presently has a consensus rating of "Buy" and an average price target of $133.67.

Insider Buying and Selling

In related news, EVP Roberton James Stevenson sold 2,250 shares of the company's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares of the company's stock, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,750 shares of company stock valued at $4,930,750. Corporate insiders own 4.60% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.